Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
Thursday 01 February 2024 3:37 pm  |  Updated:  Monday 05 February 2024 10:10 pm

Almost half of patients unaware of Government’s Pharmacy First scheme

By: Laura Forsyth

Add as a preferred source on Google
Patients can now receive treatment for seven common conditions without visiting a GP, thanks to a revamp of pharmacy services.
Patients can now receive treatment for seven common conditions without visiting a GP, thanks to a revamp of pharmacy services.

Patients can now receive treatment for seven common conditions without visiting a GP, thanks to a revamp of pharmacy services.

But despite the launch of the government and NHS England’s Pharmacy First scheme, nearly half of patients remain unaware of this initiative, according to a YouGov poll of 2,028 people across England, Scotland, and Wales.

The Pharmacy First Service (PFS) aims to position pharmacies as the frontline of healthcare, offering initial contact for patients and enhancing accessibility, especially with the NHS waiting list in England reaching 7.6 million. However, the survey indicates that only 23 per cent of patients presently consider pharmacies their first choice for minor conditions.

Upon learning about the PFS, 56 per cent of patients expressed willingness to turn to pharmacists instead of GPs for certain conditions, highlighting the need for increased awareness of pharmacy services. The survey, conducted by Charac, an NHS-integrated platform for community pharmacies, sheds light on the crucial role these establishments can play.

The seven conditions for which pharmacists can issue prescriptions include earache, uncomplicated urinary tract infections, sore throat, sinusitis, impetigo, shingles, and infected insect bites. Furthermore, patients can now obtain oral contraception directly from a pharmacy without the need to consult a practice nurse or GP.

Seven conditions pharmacists will be able to issue prescriptions for:

  • Sinusitis
  • Sore throat
  • Earache
  • Infected insect bites
  • Impetigo
  • Shingles
  • Uncomplicated urinary tract infections in women

Furthermore, a Pharmaceutical Services Negotiating Committee (PSNC) 2023 Pharmacy Pressures Survey
found that 81 per cent of pharmacy staff are ‘struggling to cope’ due to a significant rise in workload, and a
recent Education England (HEE) survey found that community vacancies doubled between
2017 and 2022.

Santosh Sahu, founder and CEO of Charac, said: “This sector has long voiced its concerns
about the introduction of Pharmacy First and we have seen first-hand how many community branches
are struggling to cope with an increase in demand.

“Ultimately, Pharmacy First will be vital in ensuring patients have easier access to healthcare, and for pharmacies to be able to provide a greater array of services to not only help their patients but also put them on a more sustainable financial position.

“Key to pharmacies being able to deliver on the new policy, we believe, is the digitisation of the sector,
giving them an online platform where they can more efficiently manage their administrative
processes and also offer new services, such as video consultations.

“Both funding and improved digital access can make a tangible difference in equipping them for
the future. Charac’s platform enhances pharmacies’ online presence, makes their processes more
efficient and helps them provide the broader range of services that will help take pressure off the NHS
and work to improve the nation’s health.”

Read more

Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Life&Style

Categories

  • Wellness

Related Topics

  • Health

Trending Articles

  • Burnham tax plans spark investor rush to bank capital gains

  • Brewdog chief executive quits after only one year

  • Housebuilding giants hit with £4.5bn lawsuit for allegedly overcharging buyers

  • UK ‘no longer a serious place’ says Hedge fund boss after losing £200m tax battle

  • Cruyff turn: Starmer allows pubs to stay open for England World Cup game

More from City PM

  • Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research

    Business Wire
  • Australian pharma giant Sigma quits Boots takeover talks

    Retail
    Anthony Hemmerdinger will take over the role from Seb James later this year.
  • Boots moves closer to London float but billionaire Westons circle

    Retail
    A pair of stylish and durable boots showcased on a wooden floor, highlighting their craftsmanship and premium leather qual...
  • Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

    Business Wire
  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation

    Business Wire
  • LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea

    Business Wire
  • Boots eyes £7.5bn sale in blow to hopes of London IPO

    Retail
    Boots remains one of the group’s best performing business lines, with a London float suggested as recently as last year. (Photo by Oli Scarff/Getty Images)

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy